123 related articles for article (PubMed ID: 38071794)
1. Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones.
Joch M; Wojtas KP; Torres-Gómez H; Li Y; Meyer F; Straßburger M; Kerndl V; Dahse HM; Hertweck C; Hoffmann H; Görls H; Walter K; Hölscher C; Kloss F
Eur J Med Chem; 2024 Jan; 264():116023. PubMed ID: 38071794
[TBL] [Abstract][Full Text] [Related]
2. Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones.
Schieferdecker S; Bernal FA; Wojtas KP; Keiff F; Li Y; Dahse HM; Kloss F
J Med Chem; 2022 May; 65(9):6748-6763. PubMed ID: 35502994
[TBL] [Abstract][Full Text] [Related]
3. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
[TBL] [Abstract][Full Text] [Related]
4. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.
Richter A; Narula G; Rudolph I; Seidel RW; Wagner C; Av-Gay Y; Imming P
ChemMedChem; 2022 Mar; 17(6):e202100733. PubMed ID: 34939744
[TBL] [Abstract][Full Text] [Related]
5. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones.
Seidel RW; Richter A; Goddard R; Imming P
Chem Commun (Camb); 2023 Apr; 59(32):4697-4715. PubMed ID: 36974371
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation and bioassay-guided isolation of antimycobacterial compounds from Morella salicifolia root ethanolic extract.
Marealle AI; Innocent E; Andrae-Marobela K; Qwarse M; Machumi F; Nondo RSO; Heydenreich M; Moshi MJ
J Ethnopharmacol; 2022 Oct; 296():115501. PubMed ID: 35752260
[TBL] [Abstract][Full Text] [Related]
10. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
[TBL] [Abstract][Full Text] [Related]
12. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
14. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
[TBL] [Abstract][Full Text] [Related]
15. hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.
Lv K; Wang A; Tao Z; Fu L; Liu H; Wang B; Ma C; Wang H; Ma X; Han B; Wang A; Zhang K; Liu M; Lu Y
Eur J Med Chem; 2019 Oct; 179():208-217. PubMed ID: 31254922
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
[TBL] [Abstract][Full Text] [Related]
17. Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State.
Liu R; Krchnak V; Brown SN; Miller MJ
ACS Med Chem Lett; 2019 Oct; 10(10):1462-1466. PubMed ID: 31620234
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.
Rouan MC; Lounis N; Gevers T; Dillen L; Gilissen R; Raoof A; Andries K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1444-51. PubMed ID: 22155815
[TBL] [Abstract][Full Text] [Related]
19. 6-Oxo and 6-thio purine analogs as antimycobacterial agents.
Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
Bioorg Med Chem; 2013 Apr; 21(7):1685-95. PubMed ID: 23434367
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
